High-content phenotypic and pathway profiling to advance drug discovery in diseases of unmet need
{{output}}
Conventional thinking in modern drug discovery postulates that the design of highly selective molecules which act on a single disease-associated target will yield safer and more effective drugs. However, high clinical attrition rates and the lack of progress i... ...
